FDA Inspection
Pharmazell (India) Private LimitedPharmazell (India) Private Limited – FDA Inspection, Aug 11, 2017
Record Details
This FDA Inspection record concerns Pharmazell (India) Private Limited, with an inspection on August 11, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 0c99397e-3b32-4ba5-9fb3-2f008a80a9a1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1022302
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Pharmazell (India) Private Limited
4| Date | Classification | Office | Project area |
|---|---|---|---|
| May 9, 2025 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 20, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 20, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 10, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pharmazell (India) Private Limited
- FDA Inspection 1274174 - 2025-05-09
- FDA Inspection 1141378 - 2020-02-20
- FDA Inspection 885795 - 2014-06-20
- FDA Inspection 754977 - 2011-11-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.